Technology, Consumer Staples, Healthcare Feb 23, 2022 06:09 PM (GMT+8) · EqualOcean
Ruikang pharmaceutical received the letter of concern from Shenzhen Stock Exchange. It is required to explain the reason and purpose of repurchasing at a high premium in a short time after the transfer of the equity of the subsidiary, and whether there is any situation of transferring interests to related parties and damaging the interests of the listed company. Verify and supplement the reasons why the book value of the equity investment of the target company in the six subsidiaries is 0, supplement and disclose the reasons why the equity evaluation value of the relevant subsidiaries is still high under such circumstances, and supplement and disclose the specific evaluation parameters and calculation process.

This text is a result of machine translation.